Announcement of Listed Companies in Shanghai Stock Exchange (December 23rd)

　　Tonghua dongbao: THDBH151 tablets were approved for clinical application.

　　() On the evening of December 22nd, it was announced that Dongbao Zixing, a wholly-owned subsidiary of the company, had recently obtained the approval notice for clinical trial of THDBH151 tablets issued by National Medical Products Administration Drug Evaluation Center. THDBH151 tablet is a double-target inhibitor of gout. Because of its special advantages in mechanism, it can not only inhibit xanthine oxidase (XO) and reduce uric acid production from the source, but also inhibit the reabsorption of uric acid by renal tubular URAT1 transporter and accelerate uric acid excretion.

　　Textile City: The share repurchase ratio reaches 4% of the total share capital.

　　() Announcement: As of December 22, the company has repurchased 60.18 million shares of the company by centralized bidding, accounting for 4.11% of the company’s total share capital. The highest price of the repurchase transaction is 4.50 yuan/share, and the lowest price is 4.08 yuan/share, with a total transaction amount of 262 million yuan (excluding transaction costs).

　　(): GDR is issued and listed on the Swiss Stock Exchange with conditional approval from the Swiss Stock Exchange Supervision Bureau.

　　Huayou Cobalt announced that the company recently obtained the conditional approval from the Swiss Stock Exchange Regulatory Authority on the issuance of global depositary receipts ("GDR") and listing on the Swiss Stock Exchange. The Swiss Stock Exchange Regulatory Authority agreed that the GDR issued by the company should be listed on the Swiss Stock Exchange after meeting the customary conditions.

　　The cumulative repurchase ratio of textile city reached 4.11%, costing 262 million yuan.

　　Textile City announced that by December 22, 2022, the company had bought back 60.176 million shares of the company by centralized bidding, accounting for 4.11% of the company’s total share capital. The highest price of the repurchase transaction was 4.50 yuan/share, the lowest price was 4.08 yuan/share, and the total transaction amount was 262 million yuan (excluding transaction costs).

　　Guang ‘an Aizhong was approved to issue corporate bonds of no more than RMB 1 billion.

　　() Announcement. Recently, the company received the Reply on Agreeing to the Registration of Sichuan Guang ‘an Aizhong Co., Ltd. to Publicly Issue Corporate Bonds to Professional Investors issued by the China Securities Regulatory Commission, and agreed to the company’s application for registration of publicly issuing corporate bonds with a total face value of no more than 1 billion yuan to professional investors.

　　Huayou Cobalt: The issuance and listing of GDR was conditionally approved by the Supervision Bureau of Swiss Stock Exchange.

　　Huayou Cobalt announced on the evening of December 22 that the company recently obtained the conditional approval from the Swiss Stock Exchange Regulatory Authority for the company to issue global depositary receipts (GDR) and list on the Swiss Stock Exchange. The Swiss Stock Exchange Regulatory Authority agreed that the GDR issued by the company would be listed on the Swiss Stock Exchange after meeting the customary conditions.

　　New Huangpu: It is planned to plan a non-public offering of shares.

　　() Announcement, the company intends to issue shares to no more than 35 specific investors in a non-public manner, and the raised funds are intended to be used for the development and construction of real estate projects, old city reconstruction projects, long-term rental projects, etc. related to the company’s "guarantee of property and people’s livelihood", as well as supplementary liquidity and debt repayment that meet the requirements of the refinancing policy of listed companies. The number of shares to be issued in this non-public offering shall not exceed 30% of the total share capital of the company before this offering, and the final number of shares to be issued shall be subject to the number approved by China Securities Regulatory Commission.

　　Hao Jing Bo Rui, the major shareholder of Chenguang New Materials, intends to reduce its holdings by no more than 1.8 million shares.

　　() Announcement: Jiangsu Hao Jing Bo Rui Landscaping Engineering Co., Ltd. ("Hao Jing Bo Rui"), a shareholder holding 5.18% of the company’s shares, intends to reduce the number of shares of the company by no more than 0.75% of the total shares of the company, that is, no more than 1.8 million shares.

　　ST Jiuyou: Shanghai High Court rejected Han Yue’s appeal and upheld the original judgment.

　　() Announcement: The company has received the criminal ruling of Shanghai Higher People’s Court forwarded by Tianjin Shengxin regarding the progress of the relevant case of Han Yue, the original actual controller of the company. The main contents are as follows:

　　Shanghai No.1 Intermediate People’s Court tried the case that the first branch of Shanghai People’s Procuratorate accused the defendant Han Yue of committing the crime of fund-raising fraud, and on December 29, 2021, it made a criminal judgment of (2019) No.94 at the beginning of Shanghai 01 sentence. Han Yue, the defendant in the original trial, refused to accept the appeal. After the Shanghai Higher People’s Court accepted the case, it formed a collegial panel according to law. After reading the papers, interrogating the defendant and listening to the opinions of the defenders, it was considered that the facts of the case were clear and decided not to hold a trial. The trial is now over.

　　The Shanghai Higher People’s Court confirmed that the fact that the defendant Han Yue committed fund-raising fraud in the original judgment was clear, the evidence was indeed sufficient, the applicable law was correct, the sentencing was appropriate and the trial procedure was legal. The appellant’s reasons for appeal and the defender’s defense opinions are inconsistent with the facts and evidence ascertained, and have no basis in law, so the Shanghai High Court will not accept and adopt them. The Shanghai People’s Procuratorate’s suggestion that the Shanghai High Court reject the appeal and uphold the original judgment is correct and should be supported. Now, according to Article 236, Paragraph 1 (1) of the Criminal Procedure Law of People’s Republic of China (PRC), the ruling is as follows: the appeal is dismissed and the original judgment is upheld. This ruling is final.

　　Jiansheng Group holds 50,000 shares by director Jiang Feng.

　　() Announced that Jiang Feng, the shareholder, director and senior manager of the company, increased his holding of 50,000 shares of the company through the centralized bidding trading system of Shanghai Stock Exchange on December 22nd, accounting for 0.01% of the company’s total share capital.

　　New Huangpu: It is planned to raise funds through non-public offering of shares for projects related to Baojiaolou.

　　New Huangpu announced on the evening of December 22nd that the company intends to issue shares to no more than 35 specific investors in a non-public manner, and the funds raised will be used for the development and construction of real estate projects, old city reconstruction projects and long-term rental projects related to the company’s "guarantee of property and people’s livelihood", as well as supplementary liquidity and debt repayment that meet the requirements of the refinancing policy of listed companies.

　　The subsidiaries of China Power received a total of 69.99 million yuan of government subsidies.

　　() Announcement was issued. From November 8, 2022 to the disclosure date of this announcement, the subsidiaries of the company received a total of 69.99 million yuan of government subsidies related to income (unaudited), accounting for 11.42% of the company’s latest audited net profit attributable to shareholders of listed companies.

　　Chunqiu Electronics intends to bring some directors and senior executives to increase capital to Dongguan Yingmai Communication, a holding subsidiary.

　　() Announcement: The company plans to increase the capital of Dongguan Yingmai Communication Technology Co., Ltd. ("Dongguan Yingmai"), a holding subsidiary of the company, with its own funds of 23 million yuan and some directors and senior management personnel in cash. After the capital increase is completed, the company’s shareholding in Dongguan Yingmai will change from 59.17% to 64.25%.

　　Otway: winning the bid for the project of all-in-one machine for scribing and welding of about 155 million yuan.

　　Aotewei announced on the evening of December 22nd that the company won the bid for the "All-in-One Welding Project" of New Energy Technology (Quzhou) Co., Ltd., with a total bid of about 155 million yuan (including tax).

　　Wanhua Chemical Company’s MDI plant with an annual output of 400,000 tons has been fully connected.

　　() It was announced that Wanhua Chemical (Fujian) Isocyanate Co., Ltd., a holding subsidiary of the company, had an annual output of 400,000 tons of MDI, and qualified products were produced on December 22, 2022, achieving a one-time successful start-up.

　　New Huangpu plans to raise funds by non-public offering of shares for real estate projects related to "guaranteeing the property and people’s livelihood".

　　New Huangpu announced that in order to actively respond to relevant policies, ensure the company’s long-term sustainable development and optimize the capital structure, the company plans to issue shares privately to no more than 35 specific investors, and the raised funds are intended to be used for the development and construction of real estate projects, old city reconstruction projects and long-term rental projects related to the company’s "guarantee of property and people’s livelihood", as well as supplementary liquidity and debt repayment that meet the requirements of the refinancing policies of listed companies. The number of shares to be issued in this non-public offering shall not exceed 30% of the total share capital of the company before this offering, and the final number of shares to be issued shall be subject to the number approved by China Securities Regulatory Commission.

　　Nanhua futures: Nanhua Fund, a wholly-owned subsidiary, completed the registration of industrial and commercial change of capital increase and renewed its business license.

　　() Announcement: Nanhua Fund Management Co., Ltd., a wholly-owned subsidiary of the company, recently completed the registration of industrial and commercial change of capital increase and obtained the Business License renewed by Dongyang Municipal Market Supervision Administration. After the change, the registered capital of South China Fund is 250 million yuan.

　　Fucheng Group, the controlling shareholder of Fucheng, pledged 42 million shares.

　　() Announcement: Fucheng Investment Group Co., Ltd. ("Fucheng Group"), the controlling shareholder of the company, released the pledge of 42 million shares on December 21, 2022, accounting for 14.45% of its shares and 5.13% of the company’s total share capital.

　　Wang Qiaobin and Cao Liangliang, directors of Concord Electronics, have not reduced their holdings for more than half of the time.

　　() Announcement was issued. As of the disclosure date of the announcement, the time for this shareholding reduction plan has been more than half. Directors Wang Qiaobin and Cao Liangliang have not reduced their shareholding in the company, and this shareholding reduction plan has not yet been implemented.

　　Yuguang Gold Lead intends to purchase tail gas and flue gas treatment equipment from Yuguang Group, the controlling shareholder.

　　() Announcement, the company intends to purchase equipment from the controlling shareholder Henan Yuguang Gold and Lead Group Co., Ltd. (hereinafter referred to as "Yuguang Group"), specifically to purchase the tail gas denitration equipment, flue gas denitration equipment, tail gas particulate matter treatment equipment, flue gas particulate matter treatment equipment, tail gas advanced treatment equipment, etc. built by the project, so as to ensure the company’s green and environmental protection operation, and the target evaluation value is 27.861 million yuan.

　　Wenfeng shares has reduced its shareholding in TF Securities.

　　() Announcement: According to the situation of the securities market, the company sold () 122 million shares through the securities trading system of Shanghai Stock Exchange from March 3, 2022 to December 21, 2022, with a turnover of 408 million yuan (including handling fees and stamp duty). After this sale, the company no longer holds TF Securities shares.

　　Wenfeng shares has reduced its shareholding in TF Securities.

　　Wenfeng shares announced that from March 3, 2022 to December 21, 2022, according to the situation of the securities market, the company sold 122 million shares of TF Securities through the securities trading system of Shanghai Stock Exchange in the form of block trading and centralized bidding, with a turnover of 408 million yuan (including handling fees and stamp duty). After this sale, the company no longer holds TF Securities shares.

　　Xu Dong, the major shareholder of Nanwei, intends to reduce his shareholding by no more than 5.99%.

　　() Announce that Mr. Xu Dong, the shareholder holding more than 5% of the company’s shares, intends to reduce the number of shares by centralized bidding to no more than 5,849,500 shares, that is, no more than 2% of the company’s total shares; Mr. Xu Dong intends to reduce the number of shares by block trading by no more than 11,699,000 shares, that is, no more than 4% of the company’s total shares.

　　Otway added three new core technicians, including Wang Mei.

　　Otway announced that according to the strategic development plan, the company comprehensively considered the actual situation of the company’s core technology research and development, and after management research, the core technical personnel are now adjusted. Ms. Wang Mei, Mr. Weiguang Jiang and Mr. Jiang Xiaolong were newly added as the company’s core technicians. The former core technicians, Mr. Hong Xu and Mr. Ming Chengru, were no longer recognized as the company’s core technicians due to the adjustment of their work responsibilities, but they continued to work in the company.

　　As of the disclosure date of the announcement, the company’s R&D work was carried out normally, and continued to focus on the construction of R&D system. This adjustment of core technicians will not have a significant adverse impact on the company’s sustainable operation ability, R&D strength and core competitiveness.

　　Lexus Software: It is planned to buy back shares of RMB 120 million to RMB 200 million.

　　Lexus Software announced on the evening of December 22 that the company plans to buy back shares at a price of 120-200 million yuan for employee stock ownership plan or equity incentive, and the repurchase price does not exceed 16.3 yuan/share.

　　Aotewei won the bid of 155 million yuan for a new energy cutting and welding integrated machine project.

　　Aotewei announced that the company won the bid for a new energy technology (Quzhou) Co., Ltd. "All-in-one welding project", with a total bid amount of about 155 million yuan. Because the average acceptance period of equipment is about 6-9 months, affected by the specific delivery time and acceptance time of the project, the winning project will have a positive impact on the company’s operating performance in 2023.

　　Shanghai Jingxing Investment, the major shareholder of Shapu Aisi, has reduced its holdings of 370,000 shares for more than half of the implementation period.

　　() Announcement: As of December 22, 2022, Shanghai Jingxing Industrial Investment Co., Ltd. ("Shanghai Jingxing"), a shareholder holding more than 5% of the company’s shares, announced on September 1, 2022 that the shareholding reduction plan was over half, and Shanghai Jingxing reduced its holdings of 370,000 shares by centralized bidding, accounting for 0.0993% of the company’s total share capital after non-public offering.

　　New Huangpu: It is planned to issue shares to no more than 35 specific investors in a non-public manner.

　　New Huangpu issued a suggestive announcement on the planned non-public offering of shares.

　　On December 22nd, New Huangpu issued a suggestive announcement about the planned non-public offering of shares.

　　According to the announcement, in order to actively respond to relevant policies, ensure the company’s long-term sustainable development and optimize the capital structure, the company plans to issue shares to no more than 35 specific investors in a non-public manner, and the funds raised are intended to be used for the development and construction of real estate projects related to the company’s "guaranteeing the delivery of buildings and protecting people’s livelihood", old city renovation projects, long-term rental projects, and supplementary liquidity and debt repayment that meet the requirements of the refinancing policy of listed companies. The number of shares to be issued in this non-public offering shall not exceed 30% of the total share capital of the company before this offering, and the final number of shares to be issued shall be subject to the number approved by China Securities Regulatory Commission.

　　According to the announcement, up to now, this non-public offering of shares is still in the initial planning stage, and the specific plan for non-public offering of shares has not yet been determined, and there are still uncertainties in this matter.

　　Lexus Software plans to spend 120 million to 200 million yuan to buy back shares, and the repurchase price does not exceed 16.3 yuan/share.

　　Lexus software announced that the company intends to buy back shares, which will be used for employee stock ownership plan or equity incentive at an appropriate time in the future. The total amount of repurchase funds is not less than RMB 120 million (inclusive) and not more than RMB 200 million (inclusive); The repurchase price shall not exceed RMB 16.3 per share. The repurchase period is within 12 months from the date when the company’s board of directors deliberated and approved this repurchase plan.

　　Lu Zhonggeng, the shareholder of Keli Sensing, has reduced his shareholding by 0.57% for more than half of the time.

　　() Announcement was issued. Recently, the company received notices from shareholders Lu Zhonggeng and Huang Zhaoxia. As of December 22, more than half of this reduction time, Lu Zhonggeng reduced his holdings by 1,622,100 shares through centralized bidding, with a reduction ratio of 0.57%; Huang Zhaoxia did not reduce his holdings.

　　Yingkou Qiyin, the shareholder of GCL Integration, intends to transfer 5.01% of the company’s shares.

　　() Announcement, the company recently received a notice from Yingkou Qiyin Investment Management Co., Ltd. (hereinafter referred to as "Yingkou Qiyin"), the concerted action of the controlling shareholder GCL Group Co., Ltd. (hereinafter referred to as "GCL Group"), and Yingkou Qiyin and Shenzhen Qianhai () Financial Holdings Co., Ltd. (hereinafter referred to as "Qianhai Financial Holdings") signed the Share Transfer Agreement on December 21, 2022, and Yingkou Qiyin intends to

　　Xianghe Industrial acquired 6.6% equity of Zhongyuan Lida for 48 million yuan.

　　() Announced that General Technology was publicly listed on Beijing Equity Exchange to transfer 6.60% equity of Zhongyuan Lida Railway Track Technology Development Co., Ltd. (hereinafter referred to as "Zhongyuan Lida"), and the company participated in the public delisting of 6.60% equity of Zhongyuan Lida and was confirmed as the final transferee. The Company signed the Property Right Transaction Contract with General Technology, stipulating that the transferor will transfer its 6.60% equity of Zhongyuan Lida (including all the rights and obligations contained in such equity) to the Company at a total price of 48 million yuan.

　　This transaction is in line with the company’s development strategy, which is conducive to the company to further expand the track fastener business, optimize the industrial layout, deepen the cooperative relationship with the major customer Zhongyuan Lida, improve the company’s core competitiveness and continuously promote the company’s high-quality development. Zhongyuan Lida is one of the few companies in the industry with core technology and the qualification to produce and supply key parts of high-speed rail fastener system. The company’s participation in Zhongyuan Lida can produce good synergy, and the business development will form the same frequency resonance, giving full play to the advantages of both parties and achieving win-win development, which is in line with the interests of the company’s minority shareholders and investors.

　　Xianghe Industry: Transferred 6.6% equity of Zhongyuan Lida to expand track fastener business.

　　Xianghe Industrial announced on the evening of December 22 that it planned to acquire 6.6% equity of Zhongyuan Lida Railway Track Technology Development Co., Ltd. held by General Technology for 48 million yuan. Zhongyuan Lida is mainly engaged in the manufacturing integration business of railway fastener systems, and this transaction is conducive to the company’s further expansion of rail fastener business.

　　Fuda Alloy continues to promote major asset replacement and issue shares to purchase assets and raise matching funds.

　　() Announcement: The Review Committee on Mergers and Acquisitions of Listed Companies of China Securities Regulatory Commission ("China Securities Regulatory Commission") held the 22nd working meeting of the Committee on Mergers and Acquisitions in 2022 on November 30, 2022, and reviewed the company’s major asset replacement and issuance of shares to purchase assets and raise matching funds. According to the results of the meeting, the company’s major asset replacement and issuance of shares to purchase assets and raise matching funds were not approved. On December 13th, 2022, the company received the Decision on Not Approving the Application of Forda Alloy Materials Co., Ltd. for Major Asset Replacement and Issuing Shares to Purchase Assets and Raising Matching Funds issued by China Securities Regulatory Commission.

　　In view of the fact that this transaction will help the company to further improve its asset quality and scale, enhance its market competitiveness, enhance its profitability and sustainable development ability, benefit the company’s long-term development and conform to the interests of the company and all shareholders. The board of directors of the company decided to continue to promote this transaction, and the 44th meeting of the sixth board of directors was held on December 22nd, 2022, and relevant proposals were reviewed and approved.

　　Fucheng shares: 42 million shares held by Fucheng Group, the controlling shareholder, were released from pledge, accounting for 5.13% of the company’s total share capital.

　　China Fortune Link December 22-Fucheng shares announced that recently, the company received a notice from Fucheng Group, the controlling shareholder, that it had repaid part of the loan of Yanjiao Branch of Langfang Bank Co., Ltd. in advance, and some of its shares were released from pledge. The number of shares released this time is 42 million shares, accounting for 5.13% of the company’s total share capital.

　　Nanwei shares: Xu Dong, a shareholder holding more than 5% of shares, plans to reduce his holdings by no more than about 17,518,800 shares.

　　China Fortune Link December 22-Nanwei shares announced that Xu Dong, a shareholder holding more than 5% of shares, intends to reduce the number of shares by centralized bidding, and at the same time, the number of shares to be reduced by block trading is not more than about 11,699,000 shares, that is, the total reduction is not more than about 17,518,800 shares, which is not more than 5.99% of the company’s total share capital.

　　Peng Chaoyang, the fund manager of Honeycomb Fengyuan Bond, resigned.

　　Today, Honeycomb Fund Management Co., Ltd. announced the change of fund manager, Honeycomb Fengyuan Bond (Class A 012624; Class C 012625) hired Peng Chaoyang, the fund manager, and Jin Zhijie left.

　　From 2006 to 2009, Peng Chaoyang served as the investment position of Zhongbao Kanglian Life Insurance Co., Ltd.; From 2009 to 2012, he served as the investment manager of Guohua Life Insurance Co., Ltd. and from 2012 to 2016, he served as the investment manager of soochow securities Co., Ltd.; From 2016 to 2018, he served as the director of fixed income of Caitong Fund Management Co., Ltd.; From 2018 to January 2022, he served as the investment director of Xiangao (Suzhou) Asset Management Co., Ltd.; Joined the Honeycomb Fund in February 2022 as a senior bond researcher; Since December 22, 2022, he has served as the fund manager of Honeycomb Fengyuan Bond Securities Investment Fund.

　　Honeycomb Fengyuan Bonds A and C were established on August 20, 2021. By December 21, 2022, their yields this year were 2.01% and 1.70%, respectively. Since their establishment, their yields were 3.05% and 2.64%, and their accumulated net worth was 1.0304 yuan and 1.0264 yuan respectively.

　　Sinopharm Hyundai: The holding subsidiary obtained the registration certificate of cytarabine for injection.

　　() On the evening of December 22nd, it was announced that Sinopharm, a holding subsidiary, was bent on obtaining the registration certificate of cytarabine for injection. Cytarabine for injection is an antimetabolic drug, which is mainly suitable for the induction, remission and maintenance treatment of acute non-lymphocytic leukemia in adults and children.

　　The modern subsidiary of Sinopharm obtained the drug registration certificate for cytarabine for injection.

　　Sinopharm Hyundai announced that Sinopharm, a holding subsidiary of the company, wholeheartedly received the registration certificate of cytarabine for injection approved and issued by National Medical Products Administration. Cytarabine for injection is an antimetabolic drug, which is mainly suitable for the induction, remission and maintenance treatment of acute non-lymphocytic leukemia in adults and children.

　　This time, Sinopharm has obtained the drug registration certificate for cytarabine for injection, and as the first product in China that has passed the consistency evaluation, it will further enrich the company’s product layout in the field of anti-tumor and immunomodulator, help to enhance the company’s market competitiveness and bring positive influence to the company’s future development. The registration certificate of the drug will not have a significant impact on the company’s current operating performance.

　　Shanghai Nianjin, a shareholder of Fudan Microelectronics, plans to reduce its shareholding by no more than 1.8%.

　　Fudan Microelectronics announced that Shanghai Nianjin Enterprise Management Consulting Partnership (Limited Partnership) (hereinafter referred to as "Shanghai Nianjin"), a shareholder of the company, plans to reduce its shares by block trading. The reduction period is 90 consecutive natural days after three trading days from the disclosure date of this announcement, and the number of shares reduced does not exceed 14,677,800, accounting for 1.80% of the company’s total share capital.

　　Shanghai Xiba subsidiary Gongcheng Environment terminated the transfer of 100% shares of Bodu Technology.

　　() Announcement: Shanghai Xiba Gongcheng Environment Co., Ltd., a wholly-owned holding company of the company, and Beijing Jiuting Chenghuan Technology Development Co., Ltd. had previously signed the Share Transfer Cooperation Agreement on December 9, 2021, stipulating that Gongcheng Environment would transfer 100% of its shares in Zhejiang Bodu Technology Co., Ltd. to Jiuting Chenghuan. After the signing of the Share Transfer Cooperation Agreement, both parties set up a condominium account in time, but the relevant transaction plan has never been clearly supported by the land supervision department, and due to the comprehensive influence of other factors, the main contents under the agreement have not yet been fulfilled.

　　On December 21, 2022, after careful consultation between Gongcheng Environment and Jiuting City Ring, it was decided to terminate the Equity Transfer Cooperation Agreement signed in the previous period by means of the Agreement.

　　Jingneng Power: The 100,000 kW wind power project in hua county was approved.

　　() Announcement: Recently, Henan Jingneng Huazhou Thermal Power Co., Ltd., a wholly-owned subsidiary of the company, received the "Reply on the Approval of Jingneng hua county 100,000 kW Wind Power Project" issued by Huaxian Development and Reform Commission; The main information is hereby announced as follows:

　　1. In order to make full use of wind energy resources, improve the energy structure, increase the proportion of clean energy and promote economic and social development, we agree in principle to the 100,000 kW wind power project of Jingneng hua county. 2. Project Construction Location: Banpodian, Niutun, Wagangzhai and Jiaohu Town, hua county. III. Project Construction Scale: The total installed capacity of the wind power project is 100 MW. 4. The total investment of the project is 621 million yuan, and the project capital accounts for 20% of the total investment, that is, 124 million yuan, and the rest is solved by bank loans.

　　Tony Electronics: Tony Semiconductor, a subsidiary, received a government subsidy of 7,794,100 yuan related to income.

　　China Fortune announced on December 22-() that on December 22, 2022, Huzhou Dongni Semiconductor Technology Co., Ltd., a subsidiary of the company, received a revenue-related government subsidy of 7,794,100 yuan, accounting for 23.33% of the company’s audited net profit attributable to shareholders of listed companies in 2021.

　　Jingneng Power: Jingneng hua county 100,000 kW wind power project was approved.

　　On the evening of December 22nd, Jingneng Electric Power announced that its wholly-owned subsidiary, Henan Jingneng Huazhou Thermal Power Co., Ltd., received the reply from the Development and Reform Commission of hua county, and agreed to the 100,000 kW wind power project in Jingneng hua county with a total investment of 621 million yuan.

　　Wan Tai Bio has repurchased 1,585,300 shares to complete the repurchase.

　　() Announcement was issued. On December 21st, 2022, the company completed the repurchase, and has repurchased 1,585,300 shares through centralized bidding, accounting for 0.1750% of the company’s total share capital. The highest price of the repurchase transaction was 133.00 yuan/share, the lowest price was 112.74 yuan/share, and the average repurchase price was 126.26 yuan/share, which has been paid cumulatively.

　　Hu Xiankuan, Chairman of Jiaojian Co., Ltd., reduced his holdings by 1.5 million shares.

　　() Announcement: From November 28, 2022 to December 22, 2022, Hu Xiankuan, the chairman of the company, reduced his holdings of 1.5 million shares through centralized bidding.

　　Shanghai Xiba: Termination of the transfer of 100% shares of Bodu Technology Company.

　　Shanghai Xiba announced on the evening of December 22 that Gongcheng Environment, a wholly-owned holding company of the company, planned to transfer 100% shares of Zhejiang Bodu Technology Co., Ltd. to Jiuting City Ring for 146 million yuan. Because the relevant transaction plan failed to get the clear support of the land supervision department, it was decided to terminate the equity transfer cooperation agreement signed in the early stage through consultation.

　　Changjiang Investment intends to expand the business field of employee accommodation with Zhongfu’s newly established company.

　　() Announcement: In order to conform to the construction concept of the Yangtze River Delta eco-green integrated development demonstration zone, the company will expand the business field of employee accommodation. It is agreed that the company and Shanghai Zhongfu Residence Enterprise Group Co., Ltd. ("Zhongfu Residence") jointly set up the Yangtze River Delta Rental Housing (Shanghai) Operation Co., Ltd. (tentative name), with a registered capital of 20 million yuan. Changjiang Investment invested 12 million yuan in cash, accounting for 60% of its shares, and Zhongfu Residence invested 8 million yuan in cash, accounting for 40% of its shares.

　　Kang Enbei: The total flavonoids extract and oral patch of Abelmoschus manihot flower, a subsidiary, obtained the drug registration certificate.

　　() Announcement: Recently, Hangzhou Kangenbei, a wholly-owned subsidiary of the company, received the Pharmaceutical Registration Certificate of total flavonoids extract of Abelmoschus manihot flower and oral patch approved and issued by National Medical Products Administration.

　　The main function of the oral patch of total flavonoids from Abelmoschus manihot flower is to clear away heat. It is used for treating mild recurrent oral ulcer caused by heat accumulation of heart and spleen, with symptoms of oral mucosal ulcer, local redness, burning pain and so on. The total flavonoids extract of Abelmoschus manihot flower is the raw material of Abelmoschus manihot flower total flavonoids oral patch.

　　Kangenbei subsidiary Abelmoschus manihot flower total flavone extract and oral patch obtained drug registration certificate.

　　Kang Enbei made an announcement. Recently, Hangzhou Kang Enbei Pharmaceutical Co., Ltd. (hereinafter referred to as Hangzhou Kang Enbei), a wholly-owned subsidiary of the company, received the Pharmaceutical Registration Certificate of total flavonoids extract from Abelmoschus manihot flower and oral patch approved and issued by National Medical Products Administration (hereinafter referred to as National Medical Products Administration).

　　Kang Enbei: The total flavone extract of Abelmoschus manihot flower and oral patch obtained the drug registration certificate.

　　Kang Enbei announced on the evening of December 22nd that Hangzhou Kang Enbei, a wholly-owned subsidiary, had received the registration certificate of total flavone extract of Abelmoschus manihot flower and oral patch medicine approved and issued by National Medical Products Administration. The medicine is mainly used for clearing away heat from heart, and can be used for treating mild recurrent oral ulcer caused by heat accumulation of heart and spleen, with symptoms such as oral mucosal ulcer, local redness, burning pain, etc.

　　Southern Power Grid Energy Storage: The main project of Guangdong Huizhou Zhongdong Pumped Storage Power Station is scheduled to start construction on December 23rd.

　　() Announcement: Guangdong Huizhou Zhongdong Pumped Storage Power Station Project (hereinafter referred to as "Huizhou Zhongdong Project") is invested and constructed by Huizhou Zhongdong Pumped Storage Power Generation Co., Ltd. (70% owned by China Southern Power Grid Peak Regulation and Frequency Modulation Power Generation Co., Ltd., a wholly-owned subsidiary of China Southern Power Grid Energy Storage Co., Ltd., and 30% owned by China Guangdong Nuclear Power Sales Co., Ltd.), and the main project of the project is scheduled to start on December 23, 2022.

　　According to the announcement, Huizhou Zhongdong Pumped Storage Power Station is located in Zhongdong Village, Gaotan Town, Huidong County, Huizhou City, with a total installed capacity of 1.2 million kilowatts (3× 400,000 kilowatts). The main construction contents of the project are upper reservoir, lower reservoir, water conveyance and power generation system, switching station, etc., with an estimated investment of 8.373 billion yuan.

　　Southern Power Grid Energy Storage: The main project of Guangdong Huizhou Zhongdong Pumped Storage Power Station started construction.

　　Southern Power Grid Energy Storage announced on the evening of December 22 that the main project of Guangdong Huizhou Zhongdong Pumped Storage Power Station Project is scheduled to start on December 23. The total installed capacity is 1.2 million kilowatts (3× 400,000 kilowatts), and the estimated investment is 8.373 billion yuan. Huizhou Zhongdong Energy Storage Power Generation Co., Ltd. (70% owned by China Southern Power Grid Peak Regulation and Frequency Modulation Power Generation Co., Ltd. and 30% owned by China Guangdong Nuclear Power Sales Co., Ltd.) is responsible for the construction of this project.

　　7,023,400 restricted shares of China UAV will be listed and circulated on December 29th.

　　China UAV announced that the number of restricted shares listed and circulated this time totaled 7,023,400 shares, accounting for 1.0405% of the company’s total share capital, involving a total of 283 shareholders, and this part of restricted shares will be listed and circulated on December 29.

　　Jianfa Hecheng: Some directors plan to increase their shares of the company by not less than 10 million yuan.

　　() On the evening of December 22nd, it was announced that four people, including Huang Hebin, vice chairman and president of the company, planned to increase the company’s shares within six months, with a total increase of not less than 10 million yuan. There is no price range for this increase plan.

　　Some directors and senior executives of Jianfa Hecheng plan to increase their shares of the company by not less than 10 million yuan.

　　Jianfa Hecheng announced that four people, including Mr. Huang Hebin, Vice Chairman and President, Mr. Liu Zhixun and Mr. Xu Hui, Vice Presidents and Ms. Gao Weilin, Secretary of the Board of Directors, plan to increase their holdings of the company’s shares with their own funds through centralized bidding trading in the Shanghai Stock Exchange system within six months from December 26, 2022, with a total increase of not less than RMB 10 million. There is no price range for this holding plan, and the holding plan will be implemented according to the fluctuation of the company’s stock price and the overall trend of the capital market.

　　Chengdu Gas elected Wang Shouhao as the chairman.

　　() Announced that the board of directors of the company elected Mr. Wang Shouhao as the chairman of the company, elected him as a member of the strategy committee of the second board of directors of the company, nominated him as a member of the strategy committee and served as the convener of the strategy committee, with the term of office from the date of deliberation and approval by the board of directors to the date of expiration of the term of office of the second board of directors.

　　China CNOOC: The subsidiary plans to purchase 40% equity of CNNC Huihai.

　　() Announcement: New Energy Company, a wholly-owned subsidiary of the company, plans to purchase 40% equity of CNNC Huihai Wind Power Investment Co., Ltd. (hereinafter referred to as "CNNC Huihai") held by Donghai Company, a wholly-owned subsidiary of CNOOC, the actual controller of the company, with its own funds of 1.518 billion yuan.

　　This transaction can effectively promote the company’s business expansion and talent training in the field of new energy, and effectively promote the company’s green and low-carbon transformation and high-quality development. This transaction is expected to have a positive impact on the company’s financial status and operating results.

　　Energy-saving wind power plans to build four wind power projects in Hubei and Henan with a total investment of 2.617 billion yuan.

　　() Announcement, the company plans to invest in the establishment of China Energy Saving Laifeng Wind Power Generation Co., Ltd. ("Laifeng Wind Power") and China Energy Saving Xianfeng Wind Power Generation Co., Ltd. ("Xianfeng Wind Power"), both with registered capital of RMB 10 million.

　　In addition, the company plans to invest in the construction of the 250,000 kW wind energy storage integration (Phase I) project in Xiangzhou, Hubei Province ("Xiangzhou Project", with a total investment of 780 million yuan (including energy storage investment)), the 110MW wind power project in Xindeng, China ("Sudeng Phase II Project", with a total investment of 821 million yuan) and the 50MW wind power project in Tianshui, Qin Zhou ("Tianshui Project", with a total investment of 3. The total investment of the above wind power projects is 2.617 billion yuan.

　　It is reported that Xiangzhou project is an integrated wind storage project developed and constructed by the company in Hubei Province, a key area of the Yangtze River Basin, which can further expand the company’s market share in Hubei Province. The development and construction of Su-Deng Phase II project can further expand the company’s market share in Songxian region. Tianshui project will further expand the company’s market share in Gansu after its completion. Songxian project is a key project for the company to carry out industrial assistance in designated counties. After completion, it can further expand the company’s market share in Henan.

　　The controlling shareholder of Zhenhua Co., Ltd. has reduced its shareholding by 0.8% for more than half of the time.

　　() Announcement was issued. As of the announcement date, Cai Zaihua, the controlling shareholder, has reduced his holding of 4,092,600 shares through centralized bidding, accounting for about 0.8% of the company’s total share capital. The reduction plan has been reduced for more than half of the time, and the reduction plan has not yet been implemented.

　　Holding shares in China: winning two projects.

　　() On the evening of December 22nd, it was announced that the company won the bid for the expansion of Chengnan Sewage Treatment Plant in Renqiu Economic Development Zone, Hebei Province and the reclaimed water reuse project in the southern district and the expansion of Beixinzhuang Township Sewage Treatment Plant and the reclaimed water reuse project in the northern district, with a total investment of about 91,398,200 yuan. The company led a consortium with China North China Design and Research Institute of Municipal Engineering Co., Ltd. to win the bid for the EPC general contracting project of Hengshui Lake and Small Lake Ecological Restoration Project in Jizhou District of Hengshui City, with a total investment of about 85,944,800 yuan.

　　GCL Integration: The concerted action of the controlling shareholder intends to transfer 5.01% of the company’s shares by agreement.

　　On December 22, GCL-IC issued a suggestive announcement about the concerted action of the controlling shareholder to transfer part of the shares. According to the announcement, GCL Integrated Technology Co., Ltd. (hereinafter referred to as "the company" or "GCL Integrated") recently received a notice from Yingkou Qiyin Investment Management Co., Ltd. (hereinafter referred to as "Yingkou Qiyin"), Yingkou Qiyin and Shenzhen Qianhai Oriental Venture Capital Holdings Co., Ltd. (hereinafter referred to as "Qianhai Financial Holdings") signed the Share Transfer Agreement on December 21, 2022, and Yingkou Qiyin intends to transfer its 293,000,000 shares of GCL to Qianhai Financial Holdings by agreement transfer, accounting for 5.01% of the total share capital of GCL.

　　After the implementation of the measures to stabilize the share price of Weiao shares, Su Qingyan, the controlling shareholder, increased his holdings by 750,000 shares.

　　() Announcement: As of the disclosure date of the announcement, the company’s measures to stabilize the stock price have been implemented. Su Qingyan, the controlling shareholder of the company, has increased the holding of 750,000 shares of the company, accounting for 0.19% of the company’s total share capital. The accumulated holding amount is RMB 5,001,100, and the transaction price range is RMB 5.99 to RMB 8.36 per share.

　　China Holdings Co., Ltd. jointly won the bid for EPC of Hengshui Lake Small Lake Ecological Restoration Project in Jizhou District, Hengshui City.

　　China Holdings announced that the company ("the leader of the consortium") and the consortium of China North China Design and Research Institute of Municipal Engineering Co., Ltd. were confirmed as the winning bidder for the EPC general contracting project of Hengshui Lake Small Lake Ecological Restoration Project in Jizhou District, Hengshui City; The total investment of the project is about 85,944,800 yuan, and the construction period is 330 calendar days. Winning the bid for this project will further accumulate the company’s experience in wetland projects, enhance its competitiveness in the field of wetland business, and consolidate the company’s dominant position in related business fields in Hebei.

　　Nanwei shares: Shareholder Xu Dong plans to reduce his shareholding by no more than 5.99%.

　　Nanwei announced after hours on December 22nd that Xu Dong, the shareholder holding more than 5% of the shares, plans to reduce his holdings by no more than 17,518,800 shares, which is no more than 5.99% of the company’s shares. The source of the shares to be reduced is the shares obtained before IPO and transferred from the company’s equity distribution capital reserve to share capital, and the reason for the proposed reduction is personal capital demand.

　　Baida Group intends to acquire 20% equity of Zhejiang Xingan Shiye Investment Management Company to expand investment channels.

　　() Announcement: In order to further expand investment channels, on December 21st, 2022, the company ("the transferee") and Xinchuang Holding Group Co., Ltd. ("Xinchuang" or "the transferor") signed the Equity Transfer Agreement, and it is planned to acquire 20% of Zhejiang Xingan Shiye Investment Management Co., Ltd. ("Xingan Shiye" or "the target company") held by Xinchuang. Xingan Shiye is a private fund manager registered in asset management association of china.

　　It is reported that Zhejiang Baida Asset Management Co., Ltd. ("Baida Asset Management Company"), a wholly-owned subsidiary of the company, as a limited partner, subscribed 60 million yuan with its own funds to invest in Hangzhou Yuanjufeng Venture Capital Partnership (Limited Partnership) managed by Xingan Shiye, and subscribed 40 million yuan with its own funds to invest in Hangzhou Zhefeng Hongsheng Venture Capital Partnership (Limited Partnership) managed by Xingan Shiye. As of the disclosure date of the announcement, the Baida Asset Management Company has made substantial contributions to Yuanju.

　　Nanshan aluminum plans to transfer 336,000 tons of electrolytic aluminum production capacity index.

　　() Announced that in order to adjust and optimize the industrial layout and asset structure, and conform to the development of national industrial policy, the company plans to transfer 336,000 tons of electrolytic aluminum production capacity, and the corresponding electrolytic aluminum production lines are planned to be shut down and dismantled, including 78 160KA prebaked electrolyzers (with an approved capacity of 36,000 tons/year) and 412 300KA prebaked electrolyzers (with an approved capacity of 300,000 tons/year) and some supporting carbon production lines.

　　The plan of holding 0.31% shares by Xie Yulong, the specific shareholder of Dongwei Technology, was completed.

　　Dongwei Technology announced that by December 22, 2022, Mr. Xie Yulong, a specific shareholder, had accumulated 461,400 shares of the company, accounting for 0.313% of the company’s total share capital, with an increase of 63,072,900 yuan, which exceeded the planned increase of 63 million yuan. This increase plan has been implemented.

　　Sino Medical: Coronary balloon products obtained FDA certification (510).

　　Sino Medical announced on the evening of December 22nd that the company’s NC ROCKSTAR non-compliant balloon dilation catheter was certified by the US FDA (510(k)). This product is suitable for balloon catheter dilation for patients with atherosclerosis to improve myocardial perfusion and for autologous coronary artery or bypass stenosis.

　　Jianghuai Automobile plans to acquire related assets of Anhui Weilai for 1.704 billion yuan.

　　() Announced that, based on the long-term strategic cooperative relationship between Jianghuai Automobile and Anhui Weilai, in order to jointly promote the cooperation of new energy automobile manufacturing, the company plans to acquire the project assets (including equipment and tooling assets) related to the construction in progress-equipment installation project held by Weilai Automobile (Anhui) Co., Ltd. (hereinafter referred to as "Anhui Weilai"), with an estimated transaction price of 1.704 billion yuan.

　　Kangwei Century: Helicobacter pylori nucleic acid detection kit obtained medical device registration certificate

　　Kangwei announced on the evening of December 22nd that the Helicobacter pylori nucleic acid detection kit independently developed and produced by the company recently received the medical device registration certificate issued by National Medical Products Administration. The company’s Helicobacter pylori nucleic acid detection kit (PCR fluorescent probe method) is used for qualitative detection of Helicobacter pylori nucleic acid in human stool samples in vitro and for auxiliary diagnosis of Helicobacter pylori infection.

　　Sino medical coronary balloon products obtained FDA certification.

　　Sino Medical announced that in August 2022, the company submitted the registration application materials of the company’s NC ROCKSTAR non-compliant balloon dilation catheter to the US Food and Drug Administration ("FDA"). Recently, the company received a notice from the FDA that the company’s NC ROCKSTAR non-compliant balloon dilation catheter was certified by the FDA (510(k)).

　　This product is suitable for balloon catheter dilation for patients with atherosclerosis to improve myocardial perfusion and for autologous coronary artery or bypass stenosis. This product is also suitable for balloon stent (bare metal and drug-eluting stent) after delivery.

　　Hengshang Investment, the shareholder of Jiacheng International, plans to reduce its shareholding by no more than 2%.

　　() Announced that the shareholder of the company, Hengshang Investment, will reduce its shareholding in the company from 15 trading days to 6 months from the date of announcement due to financial reasons of state-owned enterprise business, and the reduction will not exceed 2% of the company’s total share capital, that is, 4.665 million shares.

　　Radio and TV Network: The creditor’s right of 94.1826 million yuan held by Radio and TV Small Loan was won by Xi ‘an Hyde Jinxin.

　　Radio and Television Network announced that Shaanxi Radio and Television Jinfu Microfinance Co., Ltd. ("Radio and Television Microfinance"), a subsidiary of the company, publicly transferred its creditor’s rights of 94.1826 million yuan, which was successfully bid by Xi ‘an Hyde Jinxin Enterprise Management Consulting Partnership (Limited Partnership) ("Xi ‘an Hyde Jinxin") on Taobao asset bidding network platform on December 21, 2022, and the final transaction price was 94.1826 million yuan.

　　Time and Space Technology won the bid for the construction project of 192 million yuan taxi network car service management platform.

　　() Announcement, the company recently received the Notice of Winning Bid from Urumqi Chengtou Urban Construction Resources Development Co., Ltd., and determined that the company was the winning bidder for the "Construction Project of Taxi Network Car Service Management Platform of Urumqi Chengtou Urban Construction Resources Development Co., Ltd.", and the winning bid amount was about 192 million yuan.

　　Zhengtai Anneng, which is planning to go public, increased its capital and shares, and 8 powerful companies entered the market with 2.23 billion yuan.

　　Source: Polaris Solar Photovoltaic Network

　　On the evening of December 22nd, () announced that Zhengtai Aneng, the holding subsidiary of the company, planned to increase capital and share to introduce investors, with a total capital increase of 2,229.4 million yuan, of which 171,982,286 yuan was included in the paid-in capital and 205,741,714 yuan was included in the capital reserve. The existing shareholders of Chint Electric and Chint Anneng have given up the preemptive right of this capital increase. After the completion of this capital increase and share expansion, Chint’s shareholding in Chint Anneng will be changed from 67.0119% to 62.3035%, and Chint Anneng will remain a holding subsidiary of Chint.

　　According to the announcement, there are 8 investors who have increased their capital and shares this time. All parties have confirmed that the pre-investment valuation of Zhengtai Anneng is RMB 28 billion (the pre-investment valuation does not include the investment amount of the first investors in this round). Zhengtai Anneng plans to increase the registered capital by 171,982,286 yuan and issue 171,982,286 new shares. The specific amount of capital increase of each party is as follows:

　　Note: The total figures in the table are directly added with the detailed figures, and if there is any difference in mantissa, it is due to rounding.

　　Zhengtai Electric said that Zhengtai Anneng is mainly engaged in household photovoltaic energy operation and service business. This capital increase and share expansion is conducive to optimizing the governance structure of Zhengtai Anneng, further enhancing its endogenous power and comprehensive competitiveness, increasing the continuous investment in its main business, providing financial support for the rapid and high-quality development of the company’s household photovoltaic business, improving the asset structure and financial situation of Zhengtai Anneng, in line with the company’s long-term development strategy, and helping to further enhance the company’s core competitive advantage.

　　In October this year, Chint announced that it planned to spin off the listing of Chint Anneng, and authorized the company and the management of Chint Anneng to start the preparatory work for the spin-off of Chint Anneng. By the end of September this year, the scale of household photovoltaic power stations in Zhengtai Anneng has exceeded 9GW, distributed in 18 provinces, autonomous regions and municipalities such as Anhui, Gansu, Guangdong and Hebei, with the scale of Henan, Hebei, Shandong and Anhui accounting for 86%.

　　New Huangpu: planning for non-public offering of shares

　　The new Huangpu announced that the company intends to issue shares to no more than 35 specific investors in a non-public manner, and the raised funds are intended to be used for the development and construction of real estate projects related to the company’s "guarantee of property and people’s livelihood", old city reconstruction projects, long-term rental projects, and supplementary liquidity and debt repayment that meet the requirements of the refinancing policy of listed companies.

　　Zhuang Kejie, secretary of the board of directors of Shangji CNC, completed the implementation of the reduction plan of 13,600 shares.

　　() Announcement was issued. On December 22, 2022, the company received a notice from Mr. Zhuang Kejie, Secretary of the Board of Directors, that Mr. Zhuang Kejie’s shareholding reduction plan had been implemented. On December 22, 2022, Mr. Zhuang Kejie, secretary of the board of directors of the company, reduced his holdings of 13,600 shares of the company by centralized bidding, accounting for 0.0033% of the company’s total share capital. After the reduction, Mr. Zhuang Kejie still holds 41,000 shares of the company, accounting for 0.0100% of the total share capital of the company.

　　Guangsheng Nonferrous Metals Co., Ltd. plans to set up a joint venture company to promote the development of mineral resources

　　() Announced that the Company has signed an Investment Cooperation Agreement with Zhuhai Runfei Mining Co., Ltd. (hereinafter referred to as Runfei Mining) and Zhuhai Fuhong Investment Co., Ltd. (hereinafter referred to as Fuhong Investment), and plans to jointly promote the production, operation and development of Wengyuan Hongling Mining Co., Ltd. (hereinafter referred to as Hongling Company) through the establishment of Guangdong Shengfeng Resource Development Co., Ltd., so as to promote Hongling Company to actively seek for mining rights.

　　The investment scale of the joint venture company is 868 million yuan and the registered capital is 425 million yuan. The company invested RMB 443 million by holding 100% equity of Hongling Company, of which RMB 217 million was included in the registered capital of the joint venture company, so the company holds 51% equity of the joint venture company. Fuhong Investment contributed 425 million yuan in cash, of which 208 million yuan was included in the registered capital of the joint venture company, so Fuhong Investment holds 49% equity of the joint venture company. Except the registered capital, other contributions totaled 443 million yuan, all of which were included in the capital reserve of the joint venture company.

　　The signing of this investment cooperation agreement marks the successful completion of the public investment invitation for the mineral resources development project of Hongling Company, which lays the foundation for further implementing the resources development strategy of Hongling Company, is an important measure for the company to further improve and upgrade the industrial development layout, and meets the requirements of the company’s overall development strategy.

　　China CNOOC: The wholly-owned subsidiary plans to purchase 40% equity of CNNC Huihai for 1.518 billion yuan.

　　China CNOOC announced on the evening of December 22nd that New Energy Company, a wholly-owned subsidiary of CNOOC, plans to purchase 40% equity of CNNC Huihai Wind Power Investment Co., Ltd. (hereinafter referred to as "CNNC Huihai") held by Donghai Company, a wholly-owned subsidiary of CNOOC, the actual controller of the company. After the transaction is completed, New Energy Company will hold 40% equity of CNNC Huihai, and CNNC Huihai will become the company’s shareholding company.

　　China Resources Sanjiu: The acquisition and holding of Kunyao Group was approved by the State Council State-owned Assets Supervision and Administration Commission.

　　() On the evening of December 22nd, the State-owned Assets Supervision and Administration Commission of the State Council agreed in principle to the overall plan of China Resources Sanjiu to acquire the controlling stake in Kunyao Group by acquiring () 3,335,500 shares held by Huali Group Co., Ltd. and 209 million shares held by Huali Pharmaceutical Group Co., Ltd..

　　Huachuang Yang ‘an: 6% equity of Huachuang Securities has been pledged to CSI Credit.

　　() Announcement: In March, the board of directors of the company decided to pledge no more than 10% equity of Huachuang Securities to CSI Credit Financing Guarantee Co., Ltd. to provide financing guarantee services for corporate bond issuance. Recently, the company has pledged 6% of the equity of Huachuang Securities to CSI Credit, and received the Notice of Registration for the Establishment of Equity Pledge issued by Guizhou Provincial Market Supervision Administration.

　　Huachuang Yangan said that this equity pledge will not have a significant impact on the company’s operation and financial situation, and the risks are controllable, and there is no harm to the interests of the company and all shareholders.

　　Hainan Rubber received compensation of 50,620,500 yuan from rubber income insurance.

　　() Announced that according to the Insurance Agreement of Hainan Rubber Income Insurance Project in 2022 signed by the company with China People’s Property Insurance Co., Ltd. Hainan Branch and China Pacific Property Insurance Co., Ltd., the insurance compensation conditions were triggered due to price fluctuation in September 2022, and the amount of insurance compensation was determined to be 50,620,500 yuan through three-party investigation and loss determination. Recently, the company has received the above compensation, and the accounting is included in other income.

　　The commercial group, the controlling shareholder of Ginza Co., Ltd., completed the increase of about 1% of the company’s shares at a cost of 27.31 million yuan.

　　() Announcement: From June 23 to December 22, 2022, Shandong Commercial Group Co., Ltd. ("Commercial Group"), the controlling shareholder of the company, increased its holding of 5,200,700 shares, accounting for about 1%, with a total holding amount of RMB 27,305,600 and an average holding price of RMB 52,504 per share. The implementation of the increase plan expires and the increase plan has been completed.

　　35,970,900 restricted shares of Pingao will be listed and circulated on December 30th.

　　Pingao shares announced that the number of shares that have been released from restricted sales and applied for listing and circulation this time is 35,970,900 shares, accounting for 31.82% of the company’s total share capital. This part of restricted shares will be listed and circulated on December 30, 2022.

　　Jiacheng International: Hengshang Investment intends to reduce its shareholding by no more than 2%.

　　Jiacheng International announced on the evening of December 22 that Guangdong Hengshang Investment Management Co., Ltd. (hereinafter referred to as "Hengshang Investment"), a shareholder holding 7.95% of the company’s shares, intends to reduce its shareholding by no more than 2%.

　　Aohua Endoscopy awarded 260,000 restricted shares to 8 incentive targets.

　　Aohua Endoscope issued an announcement, and the company reviewed and approved the Proposal on Granting Reserved Restricted Shares to the Incentive Objects of the 2022 Restricted Stock Incentive Plan, and determined December 21, 2022 as the reserved grant date, with the grant price of 22.31 yuan/share, and granted 260,000 restricted shares to eight incentive objects that met the conditions for the reserved grant.

　　Guangsheng Nonferrous Metals Co., Ltd.: Signing an investment cooperation agreement to promote the development of Wengyuan Hongling mining industry

　　Guangsheng Nonferrous announced on the evening of December 22nd that the company had signed investment cooperation agreements with Runfei Mining and Fuhong Investment, and planned to jointly promote the production, operation and development of Wengyuan Hongling Mining Co., Ltd. through the establishment of Guangdong Shengfeng Resources Development Co., Ltd.. The investment scale of the joint venture company is 868 million yuan and the registered capital is 426 million yuan. The company invested 443 million yuan with 100% equity of Hongling Company, of which 217 million yuan was included in the registered capital, so it holds 51% equity of the joint venture company. The signing of this cooperation agreement indicates that the company has successfully completed the public investment invitation for the mineral resources development project of Hongling Company.

　　Space-time Technology: Winning the bid for the construction project of taxi service management platform of taxi network.

　　Space-time Technology announced on the evening of December 22nd that the company won the bid for the construction project of taxi service management platform of Urumqi Chengtou Urban Construction Resources Development Co., Ltd., with a bid price of 192 million yuan and a cooperation period of 21 years. The construction period is 1 year and the operation period is 20 years. The bid amount accounts for about 25.72% of the company’s annual operating income in 2021.

　　Guangzhou Houbao, the shareholder of Tebao Bio, completed the reduction and accumulated a reduction of 299,900 shares.

　　Tebao Bio announced that Guangzhou Houbao, the shareholder of the company, has completed the implementation of the centralized bidding transaction reduction plan, with a cumulative reduction of 299,900 shares.

　　Jiufeng Energy shareholder Shidai Finance intends to reduce its holdings by no more than 349,000 shares.

　　() Announcement is issued. Shareholder Shidai Finance plans to reduce its holdings of the company’s shares by no more than 349,000 shares (inclusive) through centralized bidding and/or block trading, accounting for 0.0563% of the company’s total share capital, and the reduction price is not less than 24.39 yuan/share.

　　Jin Yan, supervisor of Warner Pharmaceutical Factory, completed the implementation of the reduction plan of 660,400 shares.

　　Warner Pharmaceutical Company announced that as of December 22, 2022, Mr. Jin Yan, the company’s shareholder and supervisor, had reduced the company’s shares by 660,400 shares through centralized bidding, accounting for 0.70% of the company’s total share capital, and the above reduction plan was completed.

　　Yongji Co., Ltd.: It is planned to set up a wholly-owned subsidiary to develop packaging and printing related business.

　　() On the evening of December 22nd, it was announced that it planned to set up Guizhou Qiannan Yongji Printing Co., Ltd., a wholly-owned subsidiary in Qiannan, Guizhou Province, with 50 million yuan to further develop packaging and printing related business and launch new project business.

　　Jiufeng Energy: Shidai Finance plans to reduce its shareholding by no more than 0.06%.

　　Jiufeng Energy announced on the evening of December 22nd that Starr Financial (Barbados) I, Inc (hereinafter referred to as "Shidai Finance"), the shareholder holding 6.0373% of the company’s shares, plans to reduce the company’s shares by no more than 0.0563% at a price of no less than 24.39 yuan per share.

　　Renfu Medicine corrects and retroactively adjusts the previous accounting errors.

　　On the evening of December 22nd, () issued an announcement, and the company recently held a board meeting and a board of supervisors to review and approve the Proposal on Correction and Retroactive Adjustment of Accounting Errors in the Company’s Early Period, so as to retroactively adjust the company’s consolidated financial statements from 2017 to 2021 and the financial statements of the parent company, and at the same time correct the consolidated financial statements and the financial statements of the parent company in the first three quarters of 2022.

　　According to the announcement, the board of directors, independent directors and the board of supervisors of Renfu Pharmaceutical gave their consent to the correction and retrospective adjustment of accounting errors. The Board of Directors and the Board of Supervisors of the Company agreed that the correction and retrospective adjustment of accounting errors in the previous period were in line with the provisions of Accounting Standards for Business Enterprises No.28-Changes in Accounting Policies and Accounting Estimates and Error Correction, and China Securities Regulatory Commission’s Rules for the Compilation of Information Disclosure of Companies Offering Securities to the Public No.19-Correction and Related Disclosure of Financial Information, which could reflect the company’s financial position and operating results more objectively and fairly, and there was no harm to the rights and interests of the company and shareholders.

　　On the day of the announcement, Daxin Certified Public Accountants issued an opinion on the audit report on the correction of accounting errors in the previous period and the retrospective adjustment. On the same day, Renfu Medicine also disclosed the revised annual report for 2021, the first quarter report for 2022, the semi-annual report for 2022 and the third quarter report for 2022 on the website of Shanghai Stock Exchange.

　　The relevant person in charge of Renfu Medicine said that after the correction and retrospective adjustment of accounting errors in the previous period, the company will not have a significant impact on the company’s assets and performance by including related companies in the scope of consolidated statements. After several years of business integration and business development, the quality of related assets is generally good, and the company will continue to operate as planned, sell as soon as possible, or cancel according to procedures; On the other hand, it can ensure the safety of related assets and fully resolve the long-term uncollected risks of other receivables, which is conducive to improving the overall asset quality of listed companies and achieving more efficient and stable development of their core business.

　　Through the correction and retrospective adjustment of accounting errors in the previous period, although the corresponding financial indicators of Renfu Pharmaceutical have changed in the past three years, the first quarter report in 2022, the semi-annual report in 2022 and the third quarter report in 2022, the overall business performance and net profit growth trend of listed companies in the past three years have not been affected. Especially in recent years, the company has made continuous breakthroughs in innovative drugs, showing a more stable development trend. (Cheng Wei)

　　Jiamao Information, the shareholder of Yongxin Optics, intends to reduce its holdings by no more than 400,000 shares.

　　() Announced that the shareholder Jiamao Information plans to reduce the company’s shares by means of centralized bidding, block trading and other laws and regulations, and the total amount of reduction will not exceed 400,000 shares within six months after three trading days from the date of disclosure of this reduction plan announcement, accounting for 0.362% of the company’s total share capital.

　　Heyuan Bio won the real estate at No.19, Lane 908, Ziping Road, Pudong New Area, Shanghai for 98.69 million yuan.

　　Heyuan Bio-announcement, previously disclosed that the company intends to participate in bidding for the real estate ("the underlying assets") at No.19, Lane 908, Ziping Road, Pudong New Area, Shanghai, owned by Shanghai () Park Joint Development Co., Ltd. with its own funds and self-raised funds.

　　It is reported that the underlying assets are state-owned assets, and the underlying assets were listed on the Shanghai United Assets and Equity Exchange for public transfer on November 9, 2022. By the end of this bidding, the company, as the effective highest bidder for this bidding, has successfully bid, and the quoted amount is RMB 98,687,075. Recently, the company signed the "Shanghai Real Estate Sales Contract" with Shanghai International Medical Park Joint Development Co., Ltd., with a contract transaction amount of RMB 98,687,075.

　　Huiyu Pharmaceutical Co., Ltd.: Paclitaxel Injection was approved for marketing in Germany.

　　Huiyu Pharmaceutical announced on the evening of December 22nd that Seacross Pharma (Europe) Limited, a wholly-owned subsidiary, recently received a marketing license for its product paclitaxel injection approved by the German Food and Drug Administration. Paclitaxel injection is suitable for the first-line and subsequent treatment of advanced ovarian cancer.

　　Energy-saving wind power: it is planned to invest a total of 2.617 billion yuan in four wind power projects.

　　Energy-saving wind power announcement: the company plans to invest in the establishment of China Energy Saving Laifeng Wind Power Generation Co., Ltd. and China Energy Saving Xianfeng Wind Power Generation Co., Ltd., and invest in the construction of China Energy Saving 250,000 kW wind storage integration (Phase I) project in Xiangzhou, Hubei Province, China Energy Saving 110MW wind power project in Suzhou and Dengzhou, China Energy Saving 50MW wind power project in Tianshui and Qin Zhou, and China Energy Saving 100MW wind power project in Jiu Hao Town of Songxian County. The total investment of the above wind power projects is 2,616,010,000 yuan.

　　Shanghai Tewo, the major shareholder of Northern Shares, reduced its holdings by 2%.

　　() Announcement: Tewo (Shanghai) Enterprise Management Consulting Co., Ltd. ("Shanghai Tewo"), a shareholder holding more than 5% of the company’s shares, reduced its shareholding by 3.4 million shares on December 22, 2022, accounting for 2% of the company’s total share capital, and its shareholding ratio decreased from 25.16% to 23.16%.

　　Swan shares: stock price changes will be suspended for verification from December 23.

　　() It was announced on the evening of December 22nd that from October 31st to the close of December 22nd, the company’s stock had a total daily limit of 16 trading days, hitting four abnormal fluctuations, and the stock price rose by 175.32%. The company’s stock was suspended from the market opening on December 23rd, and resumed trading after the verification announcement was disclosed.

　　Shentong Technology granted 450,000 restricted shares to 40 incentive targets.

　　() Announcement was issued. The Board of Directors considered that the reserved grant conditions stipulated in the Company’s Restricted Stock Incentive Plan 2021 (Revised Draft) had been achieved, and agreed to set December 22, 2022 as the reserved grant date, and granted 450,000 restricted shares to 40 incentive targets meeting the grant conditions at a price of 4.62 yuan per share.

　　Swan shares applied for stock trading suspension verification, and suspended trading since the market opened on December 23.

　　Swan announced that the company’s stock price has recently increased significantly. From October 31, 2022 to the close of December 22, the company’s stock has accumulated a total of 16 trading days, hitting four abnormal fluctuations, and the stock price has increased by 175.32%. In view of the recent volatility of the company’s share price, in order to safeguard the interests of investors, the company checked the fluctuation of stock trading. Upon the application of the company, the company’s stock (stock abbreviation: Swan shares; Stock code: 603029) Suspension of trading since the market opened on December 23, 2022, and resumption of trading after disclosure of the verification announcement.

　　Swan shares: Recently, it has touched four times of abnormal fluctuations and the stock has been suspended for verification.

　　Swan shares announced that from October 31, 2022 to the close of December 22, the company’s stock has accumulated a total of 16 trading days, hitting four abnormal fluctuations, and the stock price has increased by 175.32%, and the stock has been suspended for verification.

　　CITIC Jiantou Jing Rong Bond Fund raised in advance.

　　On the 22nd, () Jing Rong Bond Fund announced that it began to raise funds on December 15th. At present, both the total fund shares and the number of subscribers have reached the filing conditions for the fund contract to take effect, and it was decided to advance the deadline for raising funds from March 14th, 2023 to December 21st, 2022, and no subscription applications will be accepted from December 22nd (including that day).

　　Huiyu Pharmaceutical: Anti-cancer drug "Paclitaxel Injection" was approved for marketing in Germany.

　　Huiyu Pharmaceutical announced that Seacross Pharma (Europe) Limited, a wholly-owned subsidiary of the company, recently received a marketing license for the company’s product paclitaxel injection approved and issued by the German Federal Agency for Drugs and Medical Devices ("German Food and Drug Administration").

　　It is reported that paclitaxel injection is suitable for the first-line and subsequent treatment of advanced ovarian cancer; Adjuvant treatment of breast cancer patients with lymph node positive after standard chemotherapy with adriamycin; Breast cancer patients with metastatic breast cancer who failed in combination chemotherapy or relapsed within 6 months after adjuvant chemotherapy; First-line treatment of patients with non-small cell lung cancer and second-line treatment of Kaposi’s sarcoma associated with AIDS.

　　Shanghai Shuangsa, the major shareholder of Huiyu Pharmaceutical, reduced its holdings by 2.37%, and more than half of them were implemented.

　　Huiyu Pharmaceutical announced that from November 24 to December 21, 2022, Shanghai Shuangsa Enterprise Management Consulting Firm (Limited Partnership) ("Shanghai Shuangsa"), a shareholder holding more than 5% of the company’s shares, reduced its holdings by 10,031,500 shares, accounting for 2.368% of the company’s total share capital. The number of this reduction plan has been more than half, and the reduction plan has not yet been implemented.

　　The stock price has fluctuated greatly recently, and Swan shares have been suspended for verification since December 23.

　　On the evening of December 22nd, Swan announced that in view of the recent large fluctuation of the company’s share price, in order to safeguard the interests of investors, the company checked the fluctuation of stock trading. Upon the company’s application, the company’s shares were suspended from the market opening on December 23, and resumed trading after the disclosure of the verification announcement.

　　According to the announcement, the stock price of Swan shares has increased significantly recently. From October 31st to the close of December 22nd, the company’s stock has accumulated a total of 16 trading days, hitting four abnormal fluctuations, and the stock price has increased by 175.32%.

　　Xinnong Development intends to apply for compulsory execution on the outstanding asset transfer funds of Alar Zhongtai and Korla Zhongtai.

　　() Announcement. As disclosed in the previous announcement, Xinnongfa Industrial Investment Management Co., Ltd. ("Xinnongfa Company"), a wholly-owned subsidiary of the company, has transferred all the effective operating assets and supporting facilities (including inventory, fixed assets, construction in progress, intangible assets, etc.) of its production line with an annual output of 80,000 tons of viscose fiber and 100,000 tons of cotton pulp to Alar Zhongtai Textile Technology at a price of 1.17 billion yuan by way of public listing and transfer. Both parties signed the Property Rights Transaction Contract and related Supplementary Contract, and the latest payment date stipulated in the contract is December 30, 2018. As of December 30, 2018, Alar Zhongtai Textile still owes the company 269 million yuan and related interest has not been paid.

　　In August, 2020, New Agricultural Development Corporation and Aral Zhongtai reached a pre-litigation mediation and signed a civil mediation document ((2020) Bing 01 Min Chu No.3) according to the Property Right Transaction Contract and Supplementary Agreement signed by both parties and the Letter of Guarantee for Joint Liability issued by Korla Zhongtai Textile Technology Co., Ltd. ("Korla Zhongtai").

　　According to the civil mediation agreement, Alar Zhongtai should pay 100 million yuan of assets transfer to the new agricultural development company before December 20, 2022, and actually paid 30 million yuan, and the rest has not been paid. The new agricultural development company intends to apply to the court for enforcement of the unpaid transfer funds of Alar Zhongtai and Korla Zhongtai. According to the relevant provisions of the Accounting Standards for Business Enterprises, it will have a significant negative impact on the company’s performance in 2022, and it is estimated that the provision for bad debts will be about 50 million yuan.

　　China UAV: About 7,023,400 restricted shares will be lifted on December 29th.

　　China Fortune Connect December 22-China UAV announced that about 7,023,400 restricted shares of the company will be released and listed for circulation on December 29, 2022, accounting for 1.0405% of the company’s total share capital.

　　Zhuzhou Smelter Group: The reorganization will be suspended on December 28th.

　　() Announcement: The Audit Committee on Mergers and Acquisitions of Listed Companies of China Securities Regulatory Commission ("China Securities Regulatory Commission") is scheduled to hold a working meeting at 9:00 a.m. on December 28th, 2022 to review the company’s issuance of shares, payment of cash to purchase assets, raising matching funds and related transactions. The company’s shares will be suspended on the day of the working meeting of the M&A and Restructuring Committee.

　　Haimuxing received a government subsidy of 11.8 million yuan in the past month.

　　Haimuxing announced that from November 22, 2022 to December 22, 2022, the company received a total of 11,799,500 yuan of government subsidies, all of which were related to income.

　　(): verify the problems listed in the decision of administrative supervision measures of Liaoning Securities Regulatory Bureau and formulate the rectification plan.

　　ST Shuguang announced on the evening of December 22nd that after the company received the decision on administrative supervision measures issued by Liaoning Securities Regulatory Bureau, the board of directors attached great importance to it, and immediately notified and conveyed it to all directors, supervisors, senior managers and personnel of relevant departments of the company. On the day of receipt, the company verified the problems listed in the decision, formulated the rectification plan according to the actual situation of the company, and clarified the responsibilities.

　　In terms of standardized operation, the Nomination Management Committee of the Board of Directors of the Company will continuously strengthen standardized operation, strictly perform its duties and procedures, and ensure that all senior executives who meet the requirements and conditions of the Company are nominated by the Nomination Committee of the Board of Directors and reviewed by the Board of Directors.

　　The remuneration Committee of the company’s board of directors will ensure that the standardized operation is strengthened. The company plans to finalize the business management plan for 2023 in January 2023 and hold a special meeting of the remuneration committee of the board of directors. The main contents of the topic include: according to the requirements, according to the main scope of work, responsibilities and importance of directors and senior management positions and the salary level of related positions in other related enterprises, formulate the salary standards and welfare standards for senior executives in 2023; Review the salary policy and implementation plan of employees in 2023. In addition, it includes the salary policy and implementation plan in 2023, including but not limited to performance evaluation standards, procedures and main evaluation systems, reward and punishment systems and standards; Review the performance of duties of directors and senior managers of the company, and conduct annual performance appraisal for them in 2022.

　　The Strategy Committee of the Board of Directors of the Company will study and make suggestions on major projects or contracts such as technical transformation, foreign investment, entrusted wealth management, etc. with a turnover of more than 10 million yuan (excluding this amount) to ensure that the duties of the Strategy Committee of the Board of Directors are fulfilled in place. The company plans to hold a special meeting of the Strategy Committee of the Board of Directors in 2022 in late December, and make research and suggestions on the company’s medium-and long-term strategic planning, so as to guide the company’s medium-and long-term strategic development.

　　In terms of information disclosure, the company will do a good job in information disclosure in the future in strict accordance with the requirements of Liaoning Securities Regulatory Bureau, adhere to the continuity and consistency of information disclosure, and may not make selective disclosure.

　　ST Shuguang said that the company is deeply aware of the shortcomings in corporate governance and information disclosure, and will seriously and continuously improve its standard operation ability, strengthen internal control supervision and inspection, further improve and improve the governance level and information disclosure quality, earnestly safeguard the legitimate rights and interests of the company and all shareholders, and realize the standardized, sustained, stable and healthy development of the company.

　　Southern Power Grid Energy Storage: The main project of Huizhou Zhongdong Pumping and Storage Power Station started on December 23rd.

　　Southern Power Grid Energy Storage announced on the evening of December 22nd that Guangdong Huizhou Zhongdong Pumped Storage Power Station Project (referred to as "Huizhou Zhongdong Project") is a key implementation project of Guangdong Province in the "Tenth Five-Year Plan" of the National Energy Administration’s Medium and Long-term Development Plan for Pumped Storage (2021-2035). Huizhou Zhongdong Pumped Storage Power Generation Co., Ltd. is responsible for the investment and construction, and the main project of the project is scheduled to start on December 23rd, 2022. China Southern Power Grid Peak Regulation and Frequency Modulation Power Generation Co., Ltd., a wholly-owned subsidiary of China Southern Power Grid Energy Storage, holds 70% of Huizhou Zhongdong Energy Storage Power Generation Co., Ltd.

　　The announcement shows that Huizhou Zhongdong Pumped Storage Power Station is located in Zhongdong Village, Gaotan Town, Huidong County, Huizhou City, with a total installed capacity of 1.2 million kilowatts (3× 400,000 kilowatts). After the completion of the power station, it will play an important role in promoting the large-scale development of clean energy such as wind power and photovoltaics, optimizing the power supply structure and ensuring the safe, stable and economic operation of the power system. The main construction contents of the project are upper reservoir, lower reservoir, water conveyance and power generation system, switching station, etc., with an estimated investment of 8.373 billion yuan.

　　Betray, the shareholder of Fangyuan, has reduced his holdings by 1.34%.

　　Fangyuan shares issued an announcement. On December 22, 2022, the company received the Notice Letter on Changes in Equity issued by the company’s shareholder Betray New Materials Group Co., Ltd. (hereinafter referred to as "Betray"), and learned that it reduced its holdings of the company’s shares by block trading on December 22, 2022, accounting for 1.34% of the company’s total share capital.

　　Faced with major illegal forced delisting *ST Amethyst part of the draft is overdue.

　　On the 21st, *ST Amethyst issued a risk warning announcement, and the company’s stock price increased significantly on December 20th, 2022. At the same time, the announcement disclosed a number of risk warnings, including the overdue of some commercial acceptance bills and bank acceptance bills issued by the company, and the possibility that the company may touch on major illegal acts stipulated by the exchange, and there is a risk of major illegal forced delisting.

　　The announcement shows that some commercial acceptance bills and bank acceptance bills issued by *ST Amethyst are overdue. By December 20, 2022, the total face value of overdue bills was 189.3981 million yuan, the company had paid a total of 19.8268 million yuan, and the overdue amount was 169.5713 million yuan, accounting for 6.42% of the company’s audited total assets at the end of 2021 and 10.76% of the net assets attributable to shareholders of listed companies. According to the Company, the above-mentioned overdue items may lead to the decline of the company’s financing ability, the related financial institutions may demand early repayment and file lawsuits against overdue items, and the aging period of suppliers’ payment to the company may be shortened, further aggravating the company’s financial shortage and having a negative impact on the company’s daily operations. The company may face the payment of related liquidated damages, penalty interest, etc., which will lead to the increase of the company’s financial expenses, and then have a certain impact on the company’s current profit or future profit.

　　*ST Amethyst also disclosed that it has the risk of major illegal forced delisting. On February 11, 2022, the company received the Notice of Filing from China Securities Regulatory Commission, and the actual controllers Zheng Mu and Luo Tiewei received the Notice of Filing from China Securities Regulatory Commission on June 24, 2022. China Securities Regulatory Commission decided to file an investigation on the company, Zheng Mu and Luo Tiewei because of the alleged violation of information disclosure. On November 18, 2022, the company received the Advance Notice of Administrative Punishment and Market Prohibition from China Securities Regulatory Commission. According to the confirmation in the Advance Notice, the company may touch the major illegal act stipulated in Article 12.2.2 of the Listing Rules of science and technology innovation board Stock Exchange (revised in April 2019 and revised in December 2020), and there is a risk of mandatory delisting due to major illegal acts.

　　In addition, *ST Amethyst was suspected of failing to disclose 417.9 million yuan of external guarantees in time in 2021, accounting for 22.46% of the latest audited net assets. Up to now, the company’s guarantee funds have been deducted or frozen, which has caused the company to confirm its estimated liabilities and losses. In the future, if the company can’t release the guarantee pledge, and the borrower or other guarantors can’t bear the relevant debts, it may cause the company’s credit and cash flow to be tight, which may further lead to the risks of limited business development and employee turnover, which will affect the company’s ability to continue to operate.

　　Moreover, Zheng Mu and Luo Tiewei, the actual controllers of *ST Amethyst, still have large personal debts and pending litigation matters, and their wholly-owned shares of Meizhou Zichen and Meizhou Zihui are 100% pledged, and the indirectly held shares of the company are 100% pledged. If the actual controllers cannot raise funds to solve debt and litigation problems in the future, it may lead to the risk of changes in the actual control rights of the company in the future.

　　*ST Zijing’s 2021 financial report auditing agency Zhongxi Certified Public Accountants issued an audit report on the company’s financial statements in 2021 that could not express opinions. Up to now, the company can’t express opinions in 2021, and the matters involved in the audit report of financial statements have not been resolved; The company’s internal control audit report with negative opinions in 2021; There are four directors in the company who cannot guarantee the authenticity, accuracy and completeness of the contents of the semi-annual report in 2022 and the third quarterly report in 2022.

　　Shanwaishan will be listed in science and technology innovation board on December 26th.

　　Shanwaishan announced that the company’s shares will be listed on the science and technology innovation board Stock Exchange on December 26th, 2022.

　　Rebate Technology completed the repurchase of 90,534,400 shares, and the performance promised compensation shares accounted for 11% of the total share capital.

　　() Announcement: According to the resolution of the 2021 Annual General Meeting of Shareholders, the Profit Forecast Compensation Agreement for Major Asset Restructuring and its supplementary agreement, the company repurchased 90,534,400 shares at a total price of RMB 0.97 as of the disclosure date of the announcement, accounting for 11.00% of the company’s total share capital. According to relevant regulations, the company will cancel the aforesaid shares, and the cancellation of share repurchase will not lead to any change in the company’s control rights.

　　Shanghai Xiba: Termination of the transfer of 100% shares of Bodu Technology

　　Shanghai Xiba announced that Gongcheng Environment, a wholly-owned holding company of the company, planned to transfer 100% shares of Zhejiang Bodu Technology Co., Ltd. to Jiuting City Ring for 146 million yuan. Due to the failure of the relevant transaction plan to get the clear support of the land supervision department and the comprehensive influence of other factors, both parties agreed to terminate the equity transfer cooperation agreement signed in the early stage.

　　Nanshan aluminum: It is planned to transfer the capacity index of 336,000 tons of electrolytic aluminum.

　　Nanshan aluminum announced that the company plans to transfer 336,000 tons of electrolytic aluminum production capacity index. After evaluation, the value of this production capacity index is about 2.227 billion yuan. It is estimated that after deducting various taxes and fees, this transaction will gain 1.773 billion yuan in transfer income, accounting for more than 50% of the latest audited net profit.

　　Chengdu gas: elected Wang Shouhao as the chairman of the company.

　　Chengdu Gas announced tonight that the company held the 21st meeting of the second board of directors today, and reviewed and approved the Proposal on Electing the Chairman of the Second Board of Directors and the Proposal on Electing Members of Special Committees of the Second Board of Directors. The board of directors of the company elected Wang Shouhao as the chairman of the company, elected him as a member of the strategy committee of the second board of directors of the company, nominated him as a member of the strategy committee and served as the convener of the strategy committee, with the term of office from the date of deliberation and approval by the board of directors to the date of expiration of the term of office of the second board of directors.

　　Resume of Wang Shouhao:

　　Wang Shouhao, male, born in party member, CPC, in July 1979, is of China nationality and has no permanent residency abroad, with a master’s degree. He is currently the secretary, director and chairman of the Party Committee of Chengdu Gas Group Co., Ltd., and has served as the office staff, second-class manager, deputy director and director of the board office of Chengdu Urban Construction Investment Management Group Co., Ltd., the secretary of the first party branch of the group headquarters, and the member, secretary, director and chairman of the party branch of Chengdu Tianfu Olympic Sports City Investment Development Co., Ltd.

　　Shareholders of Jiacheng International intend to reduce their holdings by no more than 2%.

　　Jiacheng International announced that the shareholder Hengshang Investment intends to reduce the company’s shares by no more than 2% of the company’s total share capital.

　　Swan shares: stock price change suspension verification

　　Swan shares announced that the company’s stock price has recently increased significantly, and the company intends to check the fluctuation of stock trading. The company’s shares have been suspended since the market opened on December 23, 2022, and resumed trading after the disclosure of the verification announcement.

　　China CNOOC: The subsidiary plans to acquire 40% equity of CNNC Huihai for 1.518 billion yuan.

　　China CNOOC announced that New Energy Company, a wholly-owned subsidiary of CNOOC, plans to purchase 40% equity of CNNC Huihai Wind Power Investment Co., Ltd. (hereinafter referred to as "CNNC Huihai") held by Donghai Company, a wholly-owned subsidiary of CNOOC, the actual controller of the company, for 1.518 billion yuan. CNNC Huihai is mainly engaged in wind power and photovoltaic power generation business investment. After the transaction is completed, the new energy company will hold 40% equity of CNNC Huihai, and CNNC Huihai will become the company’s shareholding company.

　　Jianfa Hecheng: Some senior executives plan to increase their shares by not less than 10 million yuan.

　　Jianfa Hecheng announced that four people, including Vice Chairman and President Huang Hebin, Vice Presidents Liu Zhixun and Xu Hui, and Secretary of the Board of Directors Gao Weilin, plan to increase their shares in the company by centralized bidding with their own funds within six months from December 26, 2022, with a total amount of not less than 10 million yuan.

　　Huayou Cobalt: GDR was issued and listed on the Swiss Stock Exchange and approved by the Swiss Stock Exchange Supervision Bureau.

　　Huayou Cobalt announced that the company recently obtained the conditional approval from the Swiss Stock Exchange Regulatory Authority on the issuance of global depositary receipts (GDR) and listing on the Swiss Stock Exchange. The Swiss Stock Exchange Regulatory Authority agreed that the GDR issued by the company should be listed on the Swiss Stock Exchange after meeting the customary conditions.

　　Xianghe Industry: It is planned to delist 6.6% equity of Zhongyuan Lida.

　　Xianghe Industry announced that General Technology was publicly listed on the Beijing Equity Exchange to transfer 6.60% equity of Zhongyuan Lida Railway Track Technology Development Co., Ltd. (referred to as "Zhongyuan Lida"). The company participated in the public delisting of 6.60% equity of Zhongyuan Lida and was confirmed as the final transferee. The transaction price was 48 million yuan. Zhongyuan Lida is one of the few companies in the industry with core technology and the qualification to produce and supply key parts of high-speed rail fastener system. Xianghe Industrial shares in Zhongyuan Lida, which can produce good synergy and form the same frequency resonance in business development.

　　Sinopharm Hyundai: its subsidiary has obtained the registration certificate of cytarabine for injection.

　　Sinopharm Modern announced that Sinopharm, a holding subsidiary, wholeheartedly received the registration certificate of cytarabine for injection approved and issued by National Medical Products Administration. Cytarabine for injection is an antimetabolic drug, which is mainly suitable for the induction, remission and maintenance treatment of acute non-lymphocytic leukemia in adults and children.

　　Otway: Won the bid for the 155 million yuan all-in-one welding project.

　　Aotewei announced that the company has obtained a bid-winning notice for the "All-in-one Welding Project" of New Energy Technology (Quzhou) Co., Ltd., with a total bid amount of about 155 million yuan.

　　Huaqin Technology plans to spend 66.54 million yuan to purchase related real estate to reduce related transactions.

　　Huaqin Technology announced that the company plans to purchase Building No.4 held by Shaanxi Huaqin New Energy Technology Co., Ltd. at No.188, West Avenue, High-tech Zone, Xi ‘an City, Shaanxi Province and its corresponding land use rights with self-raised funds of 66.5434 million yuan (including tax). Shaanxi Huaqin New Energy Technology Co., Ltd. is a company directly controlled by Zhe Shengyang, the actual controller and chairman of the company, and serves as a director.

　　The announcement shows that most of the assets related to Shaanxi Huaqin New Energy Technology Co., Ltd. to be purchased this time are currently leased by the company, and the rental fee is about 3.9 million yuan per year. This transaction can further reduce the related transactions between the company and related parties.

　　Lexus Software plans to buy back shares with its own funds not exceeding 200 million yuan.

　　On the evening of December 22nd, Lexus Software announced that it planned to use its own funds of no more than 200 million yuan to buy back the company’s shares by centralized bidding, and the repurchase price was no more than 16.30 yuan/share (inclusive). The implementation period of share repurchase is within 12 months from the date when the company’s board of directors deliberated and approved this share repurchase plan, and all the repurchased shares will be used for employee stock ownership plan or equity incentive at an appropriate time in the future.

　　According to the announcement, the repurchase plan was proposed by Mr. Zhang Baoquan, the company’s chairman, controlling shareholder and actual controller. He said that based on the confidence in the future development of the company and the recognition of the company’s long-term value, in order to safeguard the interests of investors, improve the company’s long-term incentive mechanism, and more closely and effectively combine the interests of shareholders, the company’s interests and employees’ personal interests to promote the healthy and sustainable development of the company, it is proposed to use the company’s own funds to buy back the company’s shares for subsequent employee stock ownership plans or equity incentives.

　　According to the company’s third quarterly report, as of September 30, 2022, the company’s total assets were 1.353 billion yuan, net assets attributable to shareholders of listed companies were 1.270 billion yuan, and current assets were 959 million yuan. If calculated according to the upper limit of 200 million yuan for this repurchase, it accounts for 14.78%, 15.75% and 20.86% of the above financial data respectively.

　　The company said that this share repurchase will further improve the company’s long-term incentive mechanism and effectively combine the personal interests of the company, shareholders and employees, which is conducive to safeguarding the interests of investors and promoting the company’s high-quality development. At the same time, according to the company’s operation and future development plan, this repurchase will not have a significant impact on the company’s operation, finance, research and development and future development, and the company has the ability to pay the repurchase price.

　　Some analysts believe that the company’s implementation of repurchase releases a positive signal and conveys to the market that the company has long-term investment value, which is conducive to safeguarding the company’s value and shareholders’ rights and interests, and enhancing and boosting investor confidence. It is worth noting that Lexus Software has been paying attention to returning investors since its listing, and has maintained a good dividend level. In recent three years, the annual cash dividend amount has reached 80,002,000 yuan.

　　The company said that in the future, based on the application of emerging technologies such as cloud computing, big data, artificial intelligence and blockchain in the financial industry, it will continue to deepen R&D and innovation, continuously enhance the company’s core competitiveness and sustainable profitability, enhance corporate value, and strive to return investors with good business performance. (Qi Hening)

　　Aozhe shares: shareholder Miao Yu holds 250,000 shares of the company.

　　Aozhe announced on December 22, 2022 that on December 22, 2022, Mr. Miao Yu increased his holding of 250,000 shares in the national share transfer system for small and medium-sized enterprises through block trading.

　　Financial Tips of Tongbi: According to public data, the operating income of Aozhe in 2021 was 3,055,604 yuan, the net profit attributable to the parent company was-1,832,033 yuan, the return on net assets was -48.51%, and the growth rate of operating income was -19.11%. At present, the sponsoring brokerage firm is Founder Securities, and the trading method is call auction Trading, which belongs to the basic level.

　　Guangsheng Nonferrous Metals Co., Ltd.: It is planned to set up a joint venture company to promote the development of Wengyuan Hongling mining industry.

　　Guangsheng Nonferrous announced that the company has signed investment cooperation agreements with Runfei Mining and Fuhong Investment, and plans to jointly promote the production, operation and development of Wengyuan Hongling Mining Co., Ltd. by establishing a joint venture company, Guangdong Shengfeng Resources Development Co., Ltd. The investment scale of the joint venture company is 868 million yuan and the registered capital is 426 million yuan. The company invested 443 million yuan with 100% equity of Hongling Company, of which 217 million yuan was included in the registered capital, so it holds 51% equity of the joint venture company. On this basis, Runfei Mining and Fuhong Investment jointly invested to set up a project company, and obtained the right to treat and sell products such as stope weathered sand, waste rock and tailings of concentrator in Hongling Project with compensation, and assumed the responsibility for its own profits and losses. The signing of this cooperation agreement indicates that the company has successfully completed the public investment invitation for the mineral resources development project of Hongling Company.

　　Huiyu Pharmaceutical: Taxol injection, a subsidiary, was approved for marketing in Germany.

　　Huiyu Pharmaceutical announced that Seacross Pharma(Europe)Limited, a wholly-owned subsidiary, recently received a marketing license for the company’s product paclitaxel injection approved by the German Food and Drug Administration.

　　China CNOOC expanded its new energy business by over 1.5 billion yuan to purchase 40% equity of CNNC Huihai.

　　On December 22nd, China CNOOC announced that its wholly-owned subsidiary plans to purchase 40% equity of CNNC Huihai Wind Power Investment Co., Ltd. with its own funds of about RMB 1.518 billion.

　　According to reports, CNNC Huihai is mainly engaged in wind power and photovoltaic power generation business investment. China CNOOC said that the transaction can effectively promote the company’s business expansion and talent training in the field of new energy, and effectively promote the company’s green and low-carbon transformation and high-quality development.

　　Sino Medical: Coronary balloon products have been certified by FDA (510).

　　Sino Medical announced that the company recently received a notice from the US FDA that the company’s NC ROCKSTAR non-compliant balloon dilation catheter was certified by the FDA (510(k)). This product is suitable for balloon catheter dilation for patients with atherosclerosis to improve myocardial perfusion and for autologous coronary artery or bypass stenosis. This product is also suitable for balloon stent (bare metal and drug-eluting stent) after delivery.

　　(): On 22nd, the manager of the company received about 18,866,900 yuan of reorganization investment corresponding to the difference in asset disposal.

　　On the evening of December 22, *ST Fangke announced that on December 22, 2022, the company manager received a reorganization investment of RMB 18,866,919.76 corresponding to the asset disposal difference. As of the date of announcement, the company manager has received a total of RMB 70 million from the auction and the balance of assets disposal.

　　Daheng Technology: The equity of the company held by Zheng Suzhen, the controlling shareholder of the company, has been continuously frozen.

　　On December 22nd, () issued an announcement about the continued freezing of the controlling shareholder’s equity. According to the announcement, Daheng New Era Technology Co., Ltd. (hereinafter referred to as "the company") received the Notice of Judicial Freeze and Judicial Transfer of Equity from China Securities Depository and Clearing Co., Ltd. Shanghai Branch (hereinafter referred to as "Zhongdeng Shanghai Branch") on December 22, 2022. Qingdao Intermediate People’s Court of Shandong Province served Zhongdeng Shanghai Branch with the Notice of Assistance in Execution ((2016) No.148 of L02 Criminal Court). According to the contents of the freezing order No.148 of L02 Criminal Court of Qingdao Intermediate People’s Court of Shandong Province, the 129,960,000 unrestricted shares of the Company held by Ms. Zheng Suzhen, the controlling shareholder of the company, continued to be frozen, and the freezing period was from 2022. This renewal includes fruits (referring to the share delivery, share transfer and cash bonus distributed through Zhongdeng Shanghai Branch).

　　Tonghua dongbao: THDBH151 tablets were approved for clinical application.

　　Tonghua dongbao announced on the evening of December 22nd that Dongbao Zixing, a wholly-owned subsidiary of the company, had recently obtained the approval notice on the clinical trial of THDBH151 tablets issued by National Medical Products Administration Drug Evaluation Center.

　　Tonghua dongbao said that in recent years, the number of patients with gout and hyperuricemia in China has obviously increased and become younger. Hyperuricemia has become the "fourth highest" after diabetes, hypertension and hyperlipidemia, and gout has become the second largest metabolic disease after diabetes. At present, drugs for treating gout mainly include xanthine oxidase inhibitors (allopurinol, febuxostat) with XO as the main target, and Urat1 inhibitors (benbromarone, resinad) which inhibit uric acid reabsorption. There is room for improvement in the effectiveness and safety of these two kinds of drugs.

　　Tonghua dongbao said that THDBH151 tablet is a double-target inhibitor of gout, because of its special advantages in mechanism, it can not only inhibit xanthine oxidase (XO), reduce uric acid production from the source, but also inhibit the reabsorption of uric acid by URAT1 transporter in renal tubules and accelerate uric acid excretion. In addition, THDBH151 tablets can balance the function of XO/Urat1 in reducing uric acid, improve the efficacy and reduce the side effects, and greatly improve the patient’s compliance, which is expected to become a Bestin-Class drug in the same field. At present, there are no similar products listed at home and abroad.

　　Kangwei Century: The first domestic kit for detecting Helicobacter pylori fecal nucleic acid was successfully listed.

　　On the evening of December 22nd, Kangwei Century announced that the Helicobacter pylori nucleic acid detection kit independently developed and produced by the company was recently awarded the Medical Device Registration Certificate (Registration CertificateNo.: 20223401755) issued by National Medical Products Administration, which is the first Class III registration certificate for Helicobacter pylori nucleic acid detection based on fecal samples in China, filling the gap in the industry and seizing the high ground.

　　It is reported that as early as 1994, the National Cancer Research Institute under WHO defined Helicobacter pylori as a class I carcinogen. In 2021, the 15th edition of the carcinogen report published by the US Department of Health and Human Services added Helicobacter pylori as a definite carcinogen. Helicobacter pylori infection is the most important risk factor for gastric cancer. The infection rate of Helicobacter pylori in Chinese population is as high as 40% ~ 60%. Helicobacter pylori infection will cause chronic inflammation and significantly increase the risk of duodenal and gastric ulcer diseases and gastric cancer. The Expert Consensus on Helicobacter Pylori Eradication and Gastric Cancer Prevention and Control in China (Shanghai, 2019) has made it clear that Helicobacter Pylori is the most important risk factor for gastric cancer and the most controllable risk factor for gastric cancer prevention. Eradication of Helicobacter Pylori should be the primary preventive measure for gastric cancer. Therefore, the screening of Helicobacter pylori is of great significance for reducing the incidence and mortality of gastric cancer.

　　It is understood that at present, clinical methods such as C13/C14 breath test, rapid urease test and fecal antigen test are mainly used to detect Helicobacter pylori. Kangwei Century has been deeply involved in the fields of nucleic acid preservation, extraction and raw material enzymes for decades, and integrated the upstream three core technologies to develop the first domestic Helicobacter pylori nucleic acid detection kit based on fecal samples. Compared with other types of Helicobacter pylori detection products, the extracted nucleic acid not only has the advantages of high sensitivity and strong specificity, but also can be used for the detection of corresponding virulence factor genes and multiple antibiotic resistance genes, which can provide a more accurate treatment plan for the eradication of Helicobacter pylori, improve the eradication rate of Helicobacter pylori and reduce the incidence of gastric cancer.

　　According to Jost Sullivan’s statistics, the market scale of Helicobacter pylori screening will be about 12 billion yuan in 2020. In the future, with the continuous improvement of public health management awareness and the listing of new technologies and new products such as Helicobacter pylori fecal nucleic acid detection kit, the penetration rate of Helicobacter pylori screening is expected to continue to increase, and the market scale of Helicobacter pylori screening will continue to grow.

　　The company believes that this Helicobacter pylori nucleic acid detection kit not only helps to enhance the competitiveness of Kangwei Century in the related fields of early screening of gastric cancer, but also has positive clinical value and social significance for early screening, early diagnosis and early treatment of gastric cancer in China. Wang Chunxiang, chairman of the company, said that Kangwei Century will take promoting the development of life science as its mission, and become an industry leader in the field of biotechnology through continuous technological innovation, so as to make every life healthy and promising.

　　Adjust the listing place Sany Heavy Industry plans to issue GDR and list it on Frankfurt Stock Exchange.

　　() Announcement, the company intends to issue Global Depositary Receipts ("GDR") and apply for listing on Frankfurt Stock Exchange, Germany. The newly issued RMB common stock (A shares) ("A shares") is used as the basic securities of GDR. The newly-added basic securities A shares represented by GDR issued by the Company this time shall not exceed 425 million shares (including the securities issued due to the exercise of any over-allotment option, if any), and shall not exceed 5% of the total share capital of the Company’s common stock before this issuance.

　　On March 16, 2022, the company disclosed its intention to issue global depositary receipts overseas and list them on the Swiss Stock Exchange. Based on the strategy of digital intelligence and the consideration of overseas industrial layout, the company plans to adjust the listing place of GDR to Germany. The company actively promotes the strategy of digital intelligence and is committed to becoming a global benchmark for intelligent manufacturing. Germany is the first in the world to launch Industry 4.0, with a number of advanced manufacturing enterprises in the world, and is at the global leading level in intelligent manufacturing. In addition, in 2012, the company acquired Putzmeister Company, a well-known global concrete equipment company, and established the largest overseas R&D and manufacturing base in Germany, which is a global construction machinery manufacturing town and one of the most important overseas markets of the company.

　　Jewater’s listing price today is 38.26 yuan/share.

　　According to the announcement of the exchange, Jewater is listed in science and technology innovation board of Shanghai Stock Exchange today. The company’s stock code is 688141, the issue price is 38.26 yuan/share, and the issue price-earnings ratio is 125.6 times.

　　Micro-nano is listed today at a price of 24.21 yuan/share.

　　According to the announcement of the exchange, Micronano is listed in science and technology innovation board of Shanghai Stock Exchange today. The company’s stock code is 688147, the issue price is 24.21 yuan/share, and the issue price-earnings ratio is 412.24 times.